Hadasit Bio-Holdings, Ltd.

Hadasit Bio-Holdings, Ltd., established in 2006, is the publicly traded subsidiary of Hadasit Ltd. - the technology transfer company of the Hadassah University Hospital, Israel’s foremost medical research center.  The Company was established for the purpose of promoting and commercializing the intellectual property and R&D capabilities generated by Hadassah.

HDSTY is the domestically traded ADR of Hadasit Bio-Holdings, a public investment vehicle of seven portfolio biotech companies all based on inventions developed and owned by Hadassah.  Hadasit Bio-Holdings focuses on advancing companies that have already shown proof of concept and successful preclinical trials to completion of Phase I and preparation for Phase II.